Victor Sandor's Net Worth
$21.9 Million
Who is Victor Sandor?
Victor Sandor has an estimated net worth of $21.9 Million. This is based on reported shares across multiple companies, which include Prelude Therapeutics Inc, Merus N.V., ARRAY BIOPHARMA INC, and Kymera Therapeutics, Inc..
SEC CIK
Victor Sandor's CIK is 0001620368
Past Insider Trading and Trends
2018 was Victor Sandor's most active year for acquiring shares with 9 total transactions. Victor Sandor's most active month to acquire stocks was the month of May. 2019 was Victor Sandor's most active year for disposing of shares, totalling 22 transactions. Victor Sandor's most active month to dispose stocks was the month of March. 2019 saw Victor Sandor paying a total of $1,284,296.30 for 267,488 shares, this is the most they've acquired in one year. In 2019 Victor Sandor cashed out on 2,003,623 shares for a total of $17,942,524.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Prelude Therapeutics Inc (PRLD) Snapshot price: $2.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Merus N.V. (MRUS) Snapshot price: $37.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARRAY BIOPHARMA INC No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -324.36K |
$48.00 |
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
$17.91 | -$2,121,000.00 | 209.54K |
Scheduled
|
Jun 4
| ||
Form 4
|
—
|
0
|
$15.60 | -$1,239,962.02 | 209.54K |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| -11.84% | -28.15K |
$15.24 | -$2,780,765.44 | 209.54K |
Scheduled
|
May 23 - May 28
| ||
Form 4
|
—
|
0
|
$15.08 | -$287,910.00 | 237.69K |
Scheduled
|
May 21
| ||
Form 4
| +3.80% | 8.69K |
$24.60 | -$170,527.20 | 237.69K |
Apr 1
| |||
Form 4
| -2.66% | -6.27K |
$14.05 | -$88,091.10 | 229K |
Scheduled
|
Dec 27
| ||
Form 4
| +5.83% | 12.97K |
$15.97 | -$165,736.66 | 235.27K |
Dec 14 - Dec 16
| |||
Form 4
| +5.81% | 12.21K |
$9.93 | -$1,402,046.13 | 222.3K |
Scheduled
|
Dec 3
| ||
Form 4
| -4.41% | -9.69K |
$15.38 | -$148,937.62 | 210.09K |
Scheduled
|
Sep 4
| ||
Form 4
| +4.61% | 9.69K |
$18.50 | -$143,430.50 | 219.77K |
Jun 27
| |||
Form 4
|
—
|
0
|
$11.21 | -$1,172,173.36 | 210.09K |
Scheduled
|
Jun 19
| ||
Form 4
|
—
|
0
|
$11.20 | -$338,602.40 | 210.09K |
Scheduled
|
Jun 13
| ||
Form 4
| -3.59% | -7.81K |
$15.78 | -$246,571.67 | 210.09K |
Scheduled
|
Apr 1 - Apr 3
| ||
Form 4
| +13.65% | 26.18K |
$10.68 | -$2,098,716.41 | 217.9K |
Scheduled
|
Mar 9
| ||
Form 4
| +3.22% | 5.97K |
$9.86 | $41,201.16 | 191.72K |
Dec 16
| |||
Form 4/A
| -4.12% | -7.30K |
$8.94 | -$65,288.82 | 170.13K |
Apr 1
| |||
Form 4
| +1.64% | 2.79K |
$8.94 | -$44,896.68 | 172.41K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
| +61.78% | 64.77K |
$3.69 | $239,012.37 | 169.62K |
Sep 22
| |||
Form 4
| -2.47% | -2.65K |
$3.00 | -$7,953.00 | 104.84K |
Apr 1
| |||
Form 4
| +151.34% | 64.73K |
$5.18 | $335,280.68 | 107.49K |
Sep 22
| |||
Form 4
| +271.31% | 31.25K |
—
|
—
| 42.77K |
Apr 1
| |||
Form 4
|
∞
| 11.63K |
$7.96 | $92,614.60 | 11.63K |
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kymera Therapeutics, Inc. (KYMR) Snapshot price: $34.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADC Therapeutics SA (ADCT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||